Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics

It seems to be a necessary need to develop an effective drug carrier system for targeted delivery of pharmaceuticals. Bacterial ghosts are emerging drug delivery platform that are capable of delivery of proteins, antigens, nucleic acids, and pharmaceuticals. Bacterial ghosts are generally produced by lysis of gram-negative bacteria. Pharmaceutically, these ghosts could be utilized to deliver proteins peptides, vaccines, drugs effectively. However, this technology is at initial stage and systematic studies are required to implement such system over humans.

• Publication year

  2014

• Venue

  International Journal of Pharmaceutical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4103/2230-973X.127733PMID 24678455PMCID 3944611
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Salmonella enteritidis ghost vaccine induces effective protection against lethal challenge in specific-pathogen-free chicks.

  2011cited by this paper
• Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of Bacterial Ghosts by human conjunctival epithelial cells.

  2011cited by this paper
• Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine.

  2010cited by this paper
• Generation of Vibrio anguillarum Ghost by Coexpression of PhiX 174 Lysis E gene and Staphylococcal Nuclease A Gene

  2009cited by this paper
• Effective gene transfer to melanoma cells using bacterial ghosts.

  2008cited by this paper
• Generation of safety enhanced Edwardsiella tarda ghost vaccine.

  2008cited by this paper
• Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula).

  2008cited by this paper
• Bacterial ghosts as adjuvant particles

  2007cited by this paper
• DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages.

  2005cited by this paper
• Immobilization of plasmid DNA in bacterial ghosts.

  2005cited by this paper
• Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts.

  2005cited by this paper
• T cell-specific immune response induced by bacterial ghosts.

  2004cited by this paper
• European union regulatory developments for new vaccine adjuvants and delivery systems.

  2004cited by this paper
• Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli

  2004cited by this paper
• Bacterial ghosts--biological particles as delivery systems for antigens, nucleic acids and drugs.

  2004cited by this paper
• Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors

  2004cited by this paper
• Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization.

  2003cited by this paper
• Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates.

  2003cited by this paper
• Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.

  2003cited by this paper
• Protective immunity against pasteurellosis in cattle, induced by Pasteurella haemolytica ghosts.

  2003cited by this paper
• Activation of Lysosomal Function During Dendritic Cell Maturation

  2003cited by this paper
• Bacterial ghosts as carrier and targeting systems

  2001cited by this paper
• Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.

  2001cited by this paper
• Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine.

  2000cited by this paper
• Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili.

  2000cited by this paper
• Dermal Microvascular Endothelial Cells Express the 180-kDa Macrophage Mannose Receptor In Situ and In Vitro1

  2000cited by this paper
• New strategies for combination vaccines based on the extended recombinant bacterial ghost system.

  1999cited by this paper
• Bacterial ghosts as drug carrier and targeting vehicles.

  1999cited by this paper
• Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coli.

  1999cited by this paper
• Cold-sensitive E-lysis systems.

  1998cited by this paper
• Effect of phi X174 protein E-mediated lysis on murein composition of Escherichia coli.

  1998cited by this paper
• Bacterial ghosts as multifunctional vaccine particles.

  1997cited by this paper
• Bacterial ghosts: non-living candidate vaccines.

  1996cited by this paper
• Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunization of mice.

  1994cited by this paper
• Pathway of PHIX174 Protein E Mediated Lysis of Escherichia coli

  1993cited by this paper
• Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E

  1990cited by this paper
• Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli.

  1989cited by this paper
• Lytic activity localized to membrane-spanning region of ϕX174 E protein

  1986cited by this paper
• Deletion and fusion analysis of the phage phi X174 lysis gene E.

  1985cited by this paper
• Candidates

  1982cited by this paper

• Engineered Streptococcus suis Bacterial Ghosts via Lytic Plasmid and Cell-Penetrating Peptides for Enhanced Protective Immunity.

  2025cites this paper
• Genetically Engineered Bacterial Ghosts as Vaccine Candidates Against Klebsiella pneumoniae Infection

  2025cites this paper
• Comparative analysis of Escherichia coli Nissle 1917 ghosts quality: a study of two chemical methods

  2024cites this paper
• The untapped potential of phage model systems as therapeutic agents

  2024cites this paper
• Production of Lactobacillus plantarum ghosts by conditional expression of a prophage-encoded holin.

  2023cites this paper
• Greenness estimation of chromatographic assay for the determination of anthracycline-based antitumor drug in bacterial ghost matrix of Salmonella typhimurium

  2022cites this paper
• Recent Update on Bacteria as a Delivery Carrier in Cancer Therapy: From Evil to Allies

  2022cites this paper
• Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917

  2022cites this paper
• Advances of bacteria-based delivery systems for modulating tumor microenvironment.

  2022cites this paper
• Efficient Robust Yield Method for Preparing Bacterial Ghosts by Escherichia coli Phage ID52 Lysis Protein E

  2022cites this paper
• Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria

  2022cites this paper
• Bacterial Ghosts-Based Vaccine and Drug Delivery Systems

  2021cites this paper
• Production of inactivated gram-positive and gram-negative species with preserved cellular morphology and integrity.

  2021cites this paper
• Bacteria from Infectious Particles to Cell Based Anticancer Targeted Drug Delivery Systems

  2021cites this paper
• Controlled expression of lysis gene E by a mutant of the promoter pL of the thermo‐inducible λcI857‐pL system

  2020cites this paper
• Vision of bacterial ghosts as drug carriers mandates accepting the effect of cell membrane on drug loading

  2020cites this paper
• The development of ghost vaccines trials

  2020cites this paper
• Formulation strategies for nose-to-brain delivery of therapeutic molecules

  2020cites this paper
• Biomimetic and bioinspired strategies for oral drug delivery.

  2020cites this paper
• Novel Therapeutic Approaches for the Treatment of Leishmaniasis

  2019cites this paper
• Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy

  2019cites this paper
• Enhanced anti-proliferative efficacy of epothilone B loaded with Escherichia coli Nissle 1917 bacterial ghosts on the HeLa cells by mitochondrial pathway of apoptosis

  2018cites this paper
• Serological and histological evaluation of species-specific immunocontraceptive vaccine antigens based on zona pellucida 3 in the small Indian mongoose (Herpestes auropunctatus)

  2018cites this paper
• Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?

  2018cites this paper
• The study of H. pylori putative candidate factors for single- and multi-component vaccine development

  2017cites this paper
• Biomimetic strategies for targeted nanoparticle delivery

  2016cites this paper
• The enhanced immune responses induced by Salmonella enteritidis ghosts loaded with Neisseria gonorrhoeae porB against Salmonella in mice.

  2016cites this paper
• The untapped potential of phage model systems as therapeutic 3 agents 4

  year unknowncites this paper